Hematopoietic Neoplasm: Clinical Trials

1 trial for Hematopoietic Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Hematopoietic Neoplasm: new trials by email Literature Review of Hematopoietic Neoplasm trials Research Report on Hematopoietic Neoplasm

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
SAR302503, Placebo - Hematopoietic Neoplasm
Phase 3TerminatedBristol-Myers Squibb2892011-12-312026-08-11

Narrower conditions

Hematologic Neoplasms (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

fedratinib (1)

Sponsors

Bristol-Myers Squibb (1)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)  ·  Lithuania (1)  ·  Mexico (1)  ·  Poland (1)  ·  Portugal (1)

Results publications

PMID 26181658